AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 216 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $6,544,000 | -34.6% | 186,964 | 0.0% | 0.24% | -35.7% |
| Q2 2020 | $9,999,000 | +50.7% | 186,964 | 0.0% | 0.38% | +27.0% |
| Q1 2020 | $6,633,000 | -35.8% | 186,964 | -13.6% | 0.30% | -23.3% |
| Q4 2019 | $10,333,000 | +124.2% | 216,408 | +52.2% | 0.39% | +94.5% |
| Q3 2019 | $4,608,000 | -36.4% | 142,217 | -2.2% | 0.20% | -32.1% |
| Q2 2019 | $7,250,000 | +17.1% | 145,342 | +58.4% | 0.30% | +17.9% |
| Q1 2019 | $6,189,000 | +173.7% | 91,776 | +87.2% | 0.25% | +158.8% |
| Q4 2018 | $2,261,000 | -13.4% | 49,025 | +44.7% | 0.10% | +2.1% |
| Q3 2018 | $2,612,000 | +1002.1% | 33,870 | +1105.3% | 0.10% | +955.6% |
| Q2 2018 | $237,000 | +3.0% | 2,810 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $230,000 | -97.6% | 2,810 | -97.2% | 0.01% | -97.6% |
| Q1 2015 | $9,458,000 | +82.7% | 100,300 | +117.1% | 0.38% | +55.0% |
| Q4 2014 | $5,176,000 | +141.1% | 46,200 | +32.0% | 0.24% | +139.6% |
| Q3 2014 | $2,147,000 | – | 35,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
| Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
| Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
| ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
| Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
| ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
| Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 614,533 | $14,115,823 | 0.09% |